Type 2 diabetes and the risk of non-Hodgkin's lymphoma: A report from two population-based cohort studies in China

European Journal of Cancer Prevention

Volumn 25, Issue 2, 2016, Pages 149-154

  Yang, Wan Shui ^a,b,c   Li, Hong Lan ^a,b   Xu, Hong Li ^a,b   Yang, Gong ^d   Gao, Yu Tang ^b   Zheng, Wei ^d   Shu, Xiao Ou ^d   Xiang, Yong Bing ^a,b  

^a School of Medicine   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c JIUJIANG UNIVERSITY   (China)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

cohort study; non Hodgkin's lymphoma; time varying covariate; type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CHINA; CHINESE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHODGKIN LYMPHOMA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SELF REPORT; COMPLICATION; INCIDENCE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84974577725     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000150     Document Type: Article

References (30)

1. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A (2011). Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 40:804-818.
2. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, et al. (2011). Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928-1937.
3. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J (2012). Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood 119:4845-4850.
4. Chao C, Page JH (2008). Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 168:471-480.
5. Cologne J, Hsu WL, Abbott RD, Ohishi W, Grant EJ, Fujiwara S, Cullings HM (2012). Proportional hazards regression in epidemiologic follow-up studies: an intuitive consideration of primary time scale. Epidemiology 23:565-573.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
7. Erber E, Lim U, Maskarinec G, Kolonel LN (2009). Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort. Int J Cancer 125:1440-1445.
8. Fisher SG, Fisher RI (2004). The epidemiology of non-Hodgkin's lymphoma. Oncogene 23:6524-6534.
9. Fortuny J, Benavente Y, Bosch R, Garcia-Villanueva M, de Sevilla AF, de Sanjose S (2005). Type 2 diabetes mellitus, its treatment and risk for lym-phoma. Eur J Cancer 41:1782-1787.
10. Giovannucci E (2003). Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 35 (11-12):694-704.
11. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997). Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241:471-475.
12. Hu FB (2011). Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249-1257.
13. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005). Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202.
14. Johnson JA, Bowker SL, Richardson K, Marra CA (2011). Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 54:2263-2271.
15. Khan AE, Gallo V, Linseisen J, Kaaks R, Rohrmann S, Raaschou-Nielsen O, et al. (2008). Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition. Haematologica 93:842-850.
16. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, Tamakoshi A, Japan Collaborative Cohort Study Group (2006). Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7:253-259.
17. Larsson SC, Wolk A (2007). Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer 121:1564-1570.
18. Lei T, Mao WM, Yang HJ, Chen XZ, Lei TH, Wang XH, et al. (2009). Study on cancer incidence through the cancer registry program in 11 cities and counties, China. Zhonghua Liu Xing Bing Xue Za Zhi 30:1165-1170.
19. Li R, Lu W, Jiang QW, Li YY, Zhao GM, Shi L, et al. (2012). Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai. Diabetes Care 35:1028-1030.
20. Mitri J, Castillo J, Pittas AG (2008). Diabetes and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 31:2391-2397.
21. Pan XR, Yang WY, Li GW, Liu J (1997). Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20:1664-1669.
22. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J (2006). Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118:2105-2109.
23. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007). Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29:115-128.
24. Villegas R, Yang G, Liu D, Xiang YB, Cai H, Zheng W, Shu XO (2007). Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men's health study. Br J Nutr 97:993-1000.
25. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. (2010). Prevalence of diabetes among men and women in China. N Engl J Med 362:1090-1101.
26. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB (2011). The role of preexisting diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 6: e27326.
27. Yang WS, Shu XO, Gao J, Li HL, Cai H, Yang G, et al. (2013). Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women. Ann Oncol 24:1679-1685.
28. Yang WS, Yang Y, Yang G, Chow WH, Li HL, Gao YT, et al. (2014). Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai. BMJ Open 4: e004875.
29. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. (2005). The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162:1123-1131.
30. Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002). Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15:83-96.